Schaeffer's Top Stock Picks for '25

Analyst Calls These 2 Drug Stocks a "Buy"

Both CRBP and NURO have been struggling on the charts

Dec 26, 2018 at 3:14 PM
facebook X logo linkedin


The shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) are trading up 5.9% at $5.57, after H.C. Wainwright initiated coverage with a "buy" rating and $24 price target -- a more than 356% premium to Monday's close. The analyst in coverage said positive data from lenabasum trials could drive upside in the shares.

Analysts are already bullish on CRBP stock, with 100% of those covering the security calling it a "buy." Plus, the average 12-month price target sits all the way up at $23.43.

Looking at the charts, Corbus Pharmaceuticals stock has been in a channel of lower highs and lows since its early October peak at $8.57. Last week, the shares broke below short-term support at their 120-day moving average, and remain down 21.6% year-to-date. Should the security resume its longer-term downtrend, a re-evaluation from the upbeat analyst bunch could create headwinds for CRBP.

crbp stock chart on dec 26

H.C. Wainwright also chimed in on Neurometrix Inc (NASDAQ:NURO), starting coverage with a "buy" rating and $5 price target -- territory the penny stock hasn't explored since April 2017. The brokerage firm said it sees "plenty of room for the stock to appreciate," and said a new generation of its Quell technology could help grow market share.

At last check, NURO stock is 13.5% higher at $0.77, but running into resistance near its 20-day moving average. While this trendline has led the security on its most recent leg lower, the 200-day moving average has helped usher the shares to a 58% year-to-date loss.

nuro stock chart on dec 26

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?